Bibliografia: Oncologia di segnale: Il futuro dell’oncologia attraverso lo studio dell’intestino

Articolo L’altra medicina N. 111 – 12/1 2022

Bibliografia

1. GLOBOCAN 2020. Available from: https://gco.iarc.fr/today/data/factsheets/populations/ 900-world-fact-sheets.pdf.
   2. Pharma, F. The Top 15 Best Selling Cancer Drugs in 2022. Available from: https:// pages.questexnetwork.com/rs/294-MQF-056/images/ The%20Top%2015%20Best%20%20Selling%20Cancer%20Drugs%20in%202022.pdf.
2. Collins, D., A.M. Hogan, and D.C. Winter, Microbial and viral pathogens in colorectal cancer. Lancet Oncol, 2011. 12 (5): p. 504-12.
   4. Lin, L. and J. Zhang, Role of intestinal microbiota and metabolites on gut homeostasis and human diseases. BMC Immunol, 2017. 18 (1): p. 2.
   5. Dzutsev, A., et al., The role of the microbiota in inflammation, carcinogenesis, and cancer therapy. Eur J Immunol, 2015. 45 (1): p. 17-31.
   6. Lisa Derosa, B.R., David Enot, Giulia Baciarello, Christophe Massard, Yohann Loriot, Karim Fizazi, Bernard J. Escudier, Laurence Zitvogel, Laurence Albiges, Impact of antibiotics on outcome in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
   7. Vetizou, M., et al., Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science, 2015. 350 (6264): p. 1079-84.